In abstract, using AI within the evaluation of blood-based biomarkers represents a big leap forward in precision psychiatry. By uncovering the molecular and genetic foundations of mental disorders, these approaches pave the way for more correct diagnoses, early interventions, and customized treatment plans [126]. Moreover, based on the scientists, the